More on AGMB
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $14.83 |
|
|||
| Open | $14.83 | ||||
| 52 Wk High | $0.01 | ||||
| 52 Wk Low | $0.01 | ||||
| Day High | $15.86 | ||||
| Day Low | $14.53 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 245,269 | ||||
- Agomab to Participate in Upcoming Investor Conferences
- Piper Sandler Starts Agomab Therapeutics (AGMB) at Overweight
- Cantor Fitzgerald Starts Agomab Therapeutics (AGMB) at Overweight
- Form 6-K Agomab Therapeutics NV For: Aug 10
- Agomab proposes two new board members ahead of shareholder vote
- Agomab Announces Proposed Appointments of Marino Garcia and Dr. Naimish Patel to Board of Directors
- Agomab proposes two new board members ahead of shareholder vote
- Agomab Announces Proposed Appointments of Marino Garcia and Dr. Naimish Patel to Board of Directors
- Form 6-K Agomab Therapeutics NV For: Aug 06
- Agomab Reports Half Year 2026 Financial Results and Confirms 2026 Outlook
Entities mentioned with AGMB
- IPO | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- JPMorgan | View Related Stories »
- Morgan Stanley | View Related Stories »
- 13G | View Related Stories »
- FDA | View Related Stories »
- Show More...
